FDA Approved: LOPID — Supplemental Application (Parke-Davis Div of Pfizer Inc)

View source ↗

Summary

The FDA approved a supplemental application for Lopid (gemfibrozil) filed by the Parke-Davis division of Pfizer Inc. The action updates the drug's labeling as p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Combined Hyperlipidemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• LOPID (Gemfibrozil)

Snippet

SUPPL AP for LOPID (GEMFIBROZIL)